Exhibit 107

Calculation of Filing Fee Tables

S-3

Acadia Pharmaceuticals Inc.

Table 1: Newly Registered and Carry Forward Securities

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial Effective Date

Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward

Newly Registered Securities

Fees to be Paid 1

Equity

Common stock, par value $0.0001 per share

Other

43,576,075

$14.84

$646,668,953.00

$0.00015310

$99,005.02

Fees Previously Paid

Carry Forward Securities

Carry Forward Securities

Total Offering Amounts:

$646,668,953.00

$99,005.02

Total Fees Previously Paid:

$0.00

Total Fee Offsets:

$0.00

Net Fee Due:

$99,005.02

Offering Note

1 Represents an aggregate of 43,576,075 shares of Acadia Pharmaceuticals Inc. common stock, par value $0.0001 per share ( “common stock”), which includes 492,407 shares of common stock that may be issued upon the exercise of warrants, held by the selling stockholders named in the prospectus that forms a part of this registration statement (this “Registration Statement”). Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement also covers any additional number of shares of common stock as may be issuable as a result of stock splits, stock dividends, or other distribution, recapitalization or similar events with respect to the shares of common stock being registered pursuant to this Registration Statement.

The proposed maximum offering price per share has been estimated in accordance with Rule 457(c) under the Securities Act solely for purposes of calculating the registration fee. The proposed maximum offering price per unit and the maximum aggregate offering price are based on the average of the high ($15.14) and low ($14.53) sale price of common stock, as reported on the Nasdaq Global Select Market on May 6, 2025, which date is within five business days prior to filing this Registration Statement.